SC
MDT icon

Stance Capital’s Medtronic MDT Stock Holding History

Stance Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,011
Closed -$1.35M – 305
2025
Q4 		$1.35M Sell
14,011
-279
-2% -$27.1K 0.49% 106
2025
Q3 		$1.36M Buy
+14,290
New +$1.31M 0.5% 83
2025
Q1 		– Sell
-160
Closed -$12.8K – 177
2024
Q4 		$12.8K Buy
+160
New +$13.9K 0.01% 169

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stance Capital's MDT Position: Q1 2026 in Review

Stance Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 14,011 shares — an estimated $1.35M sold.

Stance Capital first reported a position in MDT in Q4 2024 and held it in 3 quarters. The position peaked at $1.36M in Q3 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Stance Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Stance Capital sold 14,011 Medtronic shares in Q1 2026, an estimated $1.35M.
  • Stance Capital first reported a position in Medtronic in Q4 2024 and held it in 3 quarters.
  • Stance Capital's Medtronic position peaked at $1.36M in Q3 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.